A1,
A2,
B,
C1,
C2,
D,
E,
F,
G-H,
I-K,
L,
M,
N,
O,
P1,
P2,
Q-R,
S,
T,
U-V,
W-Z
Dermatop Side Effects, and Drug Interactions - Prednicarbate
Dermatop Side Effects, and Drug Interactions - Prednicarbate
SIDE EFFECTS
In controlled adult clinical studies, the incidence of adverse reactions probably
or possibly associated with the use of DERMATOP Emollient Cream 0.1% was approximately
4%. Reported reactions included mild signs of skin atrophy in 1% of treated
patients, as well as the following reactions which were reported in less than
1% of patients: pruritis, edema, paresthesia, urticaria, burning, allergic contact
dermatitis and rash.
In an uncontrolled study in pediatric patients with atopic dermatitis, the
incidence of adverse reactions possibly or probably associated with the use
of DERMATOP Emollient Cream 0.1% was limited. Mild signs of atrophy developed
in 5 patients (5/59, 8%) during the clinical trial, with 2 patients exhibiting
more than one sign. Two patients (2/59, 3%) developed shininess, and 2 patients
(2/59, 3%) developed thinness. Three patients (3/59, 5%) were observed with
mild telangectasia. It is unknown whether prior use of topical corticosteroids
was a contributing factor in the development of telangectasia in 2 of the patients
(See PRECAUTIONS, Pediatric Use.)
The following additional local adverse reactions have been reported infrequently
with topical corticosteroids, but may occur more frequently with the use of
occlusive dressings. These reactions are listed in an approximate decreasing
order of occurrence: folliculitis, acneiform eruptions, hypopigmentation, perioral
dermatitis, secondary infection, striae and miliaria.
DRUG INTERACTIONS
No Information Provided.
top
